ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

CTEP Drafts FDA Approval Guidelines

March 4, 1988

New Health Bills Could Affect Cancer Program

February 9, 1979

NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness

July 24, 1992

In Brief: NCI Seeking Industry Support Again For Summer Program Congress Oks Smokeless Tobacco Bill

February 14, 1986

Rogers Reaffirms Congress’ Interest In Cancer Program; Act Renewal To “Broaden, Sustain It”

April 14, 1978

NCI Funds; Ad Hoc Group Approves NCCTG Renewal

September 18, 1981